Stock listing
A3ES01 Stock Price, News, Filings & Events — Cervomed Inc.
Selected listing: A3ES01 · LSX · EUR · DE
This page tracks Cervomed Inc.'s A3ES01:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3ES01:LSX. A3ES01:LSX is the stock-level entry point for investors researching Cervomed Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cervomed Inc. (CRVO) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- A3ES01:LSX
- Asset type
- Stock
- Market cap
- $38.9M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- LSX
- Currency
- EUR
Cervomed Inc. A3ES01:LSX stock context
This page tracks Cervomed Inc.'s A3ES01:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3ES01:LSX. A3ES01:LSX is the stock-level entry point for investors researching Cervomed Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cervomed Inc. (CRVO) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Cervomed Inc.
CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfv...
September 10, 2026
CervoMed to Participate in September Investor Conferences
September 8, 2026
CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
August 10, 2026
CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord G...
August 5, 2026
CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for T...
August 4, 2026
Research Cervomed Inc.
Cervomed Inc. investor report
Review AI stock analysis and investor report context for A3ES01:LSX.
Cervomed Inc. company profile
View the public company page for Cervomed Inc. on 6ix.
Cervomed Inc. news
Read company news and market updates connected to Cervomed Inc..
Cervomed Inc. investor events
Find investor webinars, events, and replay context for Cervomed Inc..
Alternate listings
CRVO:NASDAQ
US · USD
Alternate listing for Cervomed Inc.; the primary context on this page is A3ES01:LSX.
A3ES01:LS
DE · EUR
Alternate listing for Cervomed Inc.; the primary context on this page is A3ES01:LSX.
CRVO:BOATS
US · USD
Alternate listing for Cervomed Inc.; the primary context on this page is A3ES01:LSX.
DP8:TRADEGATE
DE · EUR
Alternate listing for Cervomed Inc.; the primary context on this page is A3ES01:LSX.
DP8:FWB
DE · EUR
Alternate listing for Cervomed Inc.; the primary context on this page is A3ES01:LSX.
DP8:SWB
DE · EUR
Alternate listing for Cervomed Inc.; the primary context on this page is A3ES01:LSX.